Nepal vs Syrian Arab Republic: Cocaine use disorder deaths by sex
Nepal
4.8 deaths
in 2021
Syrian Arab Republic
4.03 deaths
in 2021
Nepal rank
34th
Syrian Arab Republic rank
36th
Cocaine use disorder deaths by sex over time
- Nepal
- Syrian Arab Republic
How they compare
Nepal currently reports 4.8 deaths against 4.03 deaths in Syrian Arab Republic, a difference of 0.77 deaths.
That makes Nepal's figure about 1.2 times Syrian Arab Republic's.
The two have swapped places 1 time across 22 shared years of data; in 2000 it was Syrian Arab Republic ahead.
Nepal ranks 34th and Syrian Arab Republic ranks 36th of 194 countries.
Across the 3 decades both report, Nepal averaged higher in 1 and Syrian Arab Republic in 2.
Head to head by decade
| Decade | Nepal | Syrian Arab Republic | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 3.19 deaths | 3.95 deaths | 0.757 deaths | Syrian Arab Republic |
| 2010s | 4.07 deaths | 4.16 deaths | 0.087 deaths | Syrian Arab Republic |
| 2020s | 4.61 deaths | 3.96 deaths | 0.645 deaths | Nepal |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cocaine use disorder deaths by sex, Nepal or Syrian Arab Republic?
- Nepal, at 4.8 deaths against 4.03 deaths in Syrian Arab Republic as of 2021.
- What is the difference in cocaine use disorder deaths by sex between Nepal and Syrian Arab Republic?
- 0.77 deaths, with Nepal ahead.
- How many years of comparable data are there for Nepal and Syrian Arab Republic?
- 22 years are reported by both, from 2000 to 2021.
- How do Nepal and Syrian Arab Republic rank globally for cocaine use disorder deaths by sex?
- Nepal ranks 34th and Syrian Arab Republic ranks 36th of 194 countries.
- Where does this data come from?
- World Health Organization (2024) β with major processing by Our World in Data, published as Cocaine use disorder deaths by sex. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Estimated number of deaths from cocaine use disorders in females.